Significance of the interleukin-1 receptor antagonist/interleukin-1β ratio as a prognostic factor in patients with pulmonary sarcoidosis

Respiration

Volumn 67, Issue 4, 2000, Pages 389-396

  Mikuniya, Takeshi ^a   Nagai, Sonoko ^a   Takeuchi, Minoru ^b   Mio, Tadashi ^a   Hoshino, Yuma ^a   Miki, Hiroyuki ^a   Shigematsu, Michio ^a   Hamada, Kunio ^a   Izumi, Takateru ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO SANGYO UNIVERSITY   (Japan)

Author keywords

Angiotensin converting enzyme activity, serum; Bronchoalveolar lavage fluid macrophages; Chest radiographs, shadows; Interleukin 1 receptor antagonist; Interleukin 1 ; Pulmonary function; Pulmonary sarcoidosis

Indexed keywords

CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

ADULT; ARTICLE; CELL CULTURE; CHRONICITY; CLINICAL ARTICLE; CYTOKINE RELEASE; DISEASE ACTIVITY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LUNG FUNCTION; LUNG LAVAGE; MACROPHAGE; MALE; PRIORITY JOURNAL; PROGNOSIS; SARCOIDOSIS; THORAX RADIOGRAPHY; VITAL CAPACITY;

EID: 0033839639     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029536     Document Type: Article

References (29)

1. James DG: Clinical picture of sarcoidosis: in Schwarz MI, King TE Jr (eds): Interstitial Lung Disease. St Louis, Mosby Year Book, 1993, pp 159-178.
2. Turner-Warwick M: Treatment of pulmonary sarcoidosis. State of art: in Grassi C, Rizzato G, Pozzi E (eds): Sarcoidosis and Other Granulomatous Disorders. Amsterdam, Elsevier, 1988, pp 621-629.
3. Hunninghake GW, Gadek JE, Young R Jr, Kawanami O, Ferrans VJ, Crystal RG: Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung. N Engl J Mcd 1980;302:594-598.
4. Hunninghake GW, Crystal RG: Pulmonary sarcoidosis: A disorder mediated by excess helper T lymphocyte activity at sites of disease activity. N Engl J Med 1981;305:429-434.
5. Nagai S, Izumi T: Pulmonary sarcoidosis: Population differences and pathophysiology. South Med J 1995;88:1001-1010.
6. Newman LS, Rose CS, Marier LA: Sarcoidosis. N Engl J Med 1997;336:1224-1234.
7. Costabel U, Bross KJ, Guzman J, Nilles A, Ruhle KH, Matthys H: Predictive value of bronchoalveolar lavage T cell subsets for the course of pulmonary sarcoidosis. Ann NY Acad Sci 1986;465:418-426.
8. Ward K, O'Connor C, Odium C, Fitzgerald MX: Prognostic value of bronchoalveolar lavage in sarcoidosis: The critical influence of disease presentation. Thorax 1989;44:6-12.
9. Mornex JF, Leroux C, Greenland T, Ecochard D: From granuloma to fibrosis in interstitial lung diseases: Molecular and cellular interactions. Eur Respir J 1994;7:779-785.
10. Hunninghake GW, Garrett KC, Richerson HB, Fantone JC, Ward PA, Rennard SI, Bitterman PB, Crystal RG: Pathogenesis of the granulomatous lung diseases. Am Rev Respir Dis 1984;130:476-496.
11. Hunninghake GW, Glazier AJ, Monick M, Dinarello CA: Interleukin-1 is a chemotactic factor for human T-lymphocytes. Am Rev Respir Dis 1987;135:66-71.
12. Kobayashi K, Allred C, Cohen S, Yoshida T: Role of interleukin-1 in experimental pulmonary granuloma in mice. J Immunol 1985;134: 358-364.
13. Boros DL: Experimental granulomatosis. Clin Dermatol 1986;4:10-21.
14. Hunninghake GW: Release of interleukin-1 by alveolar macrophages of patients with active sarcoidosis. Am Rev Respir Med 1984;129: 569-572.
15. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC: Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 1990;343:336-340.
16. Nagai S, Takeuchi M, Watanabe K, Aung H, Izumi T: Smoking and interleukin-1 activity released from human alveolar macrophages in healthy subjects. Chest 1988;94:694-700.
17. Nagai S, Aung H, Takeuchi M, Kusume K, Izumi T: IL-1 and IL-I inhibitory activity in the culture supcrnatants of alveolar macrophages from patients with interstitial lung diseases. Chest 1991;99:674-680.
18. Takeuchi M, Nagai S, Nakada H, Aung H, Satake N, Kaneshima H, Izumi T: Characterization of interleukin-1 inhibitory factor released from human alveolar macrophages as IL-I receptor antagonist. Clin Exp Immunol 1992;88:181-187.
19. Mikuniya T, Nagai S, Shimoji T, Takeuchi M, Morita K, Mio T, Satake N, Izumi T: Quantitative evaluation of the IL-1β and IL-1 receptor antagonist obtained from BALF macrophages in patients with interstitial lung diseases. Sarcoidosis Vasc Diffuse Lung Dis 1997;14:39-45.
20. Abacus Concepts, Statview. Berkeley, Abacus Concepts, 1992.
21. Costabel U: Consensus conference: Activity of sarcoidosis. Eur Respir J 1994;7:624-627.
22. Nagai S, Shigematsu M, Hamada K, Izumi T: Clinical courses and prognosis of pulmonary sarcoidosis. Curr Opin Pulm Med 1999;5:293-298.
23. Loddenkemper R, Kloppenborg A, Schoenfeld N, Grosser H, Costabel U: Clinical findings in 715 patients with newly detected pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1998;15:178-182.
24. Nagai S, Izumi T, Takeuchi M, Watanabe K, Oshima S: The effect of angiotensin II on the accessory function of BALF macrophages - a possible autostimulatory mechanism of T lymphocyte alveolitis in sarcoidosis: in Grassi C, Rizzato G, Pozzi E (eds): Sarcoidosis and Other Granulomatous Disorders. Amsterdam, Excerpta Medica, 1988, pp 129-134.
25. Nagai S, Takeuchi M, Morita K, Mikuniya T, Satake N, Mio T, Izumi T: Angiotensin II receptor on BALF macrophages from Japanese patients with active sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:67-74.
26. Arbustini E, Grasso M, Leo G, Tinelli C, Fasani R, Diegoli M, Banchieri N, Cipriani A, Gorrini M, Semenzato G, Luisetti M: Polymorphism of angiotensin-converting enzyme gene in sarcoidosis. Am J Respir Crit Care Med 1996;153:851-854.
27. Maliarik MJ, Rybicki BA, Malvitz E, Sheffer RG, Major M, Popovich J Jr, Iannuzzi MC: Angiotensin-converting enzyme gene polymorphism and risk of sarcoidosis. Am J Respir Crit Care Med 1998;158:1566-1570.
28. Takemoto Y, Sakatani M, Takami S. Tachibana T, Higaki J, Ogihara T, Miki T, Katsuya T, Tsuchiyama T, Yoshida A, Yu H, Tanio Y, Umeda E: Association between angiotensin II receptor gene polymorphism and serum angiotensin converting enzyme (SACE) activity in patients with sarcoidosis. Thorax 1998;53: 459-462.
29. Jacobs RF, Tabor DR, Burks AW, Campbell GD: Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome. Am Rev Respir Dis 1989;140:1686-1692.